This report covers a detailed review of RNA therapeutics for the treatment of cardiovascular, renal, and metabolic indications, highlighting emerging trends, recent advancements, and notable commercial activity
Key highlights include:
- RNA therapeutics now represent a significant and growing share of CVRM pipelines, with over 900 assets targeting cardiovascular, renal, and metabolic indications
- RNAi remains the dominant modality, accounting for over half of CVRM RNA assets and 75% of approved programmes, driven largely by the success of GalNAc‑based hepatic delivery.
- Extra‑hepatic delivery is a major innovation frontier, with recent high‑value deals and platform investments targeting cardiac and muscle tissue beyond the liver.
- Commercial and clinical momentum continues to build, with billion‑dollar partnerships, rapidly expanding mRNA and gene‑editing pipelines, and several late‑stage and first‑in‑class assets to watch in 2026 and beyond.
You May Also Be Interested In…
Learn More About RNA
- The Most Comprehensive Way to Search the RNA Drug Development Landscape: Unique search ontologies based on RNA drug and trial characteristics
- Market Leading Approach to RNA Preclinical & Clinical Data Curation: Manual curation of key RNA research and development data points by RNA research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search RNA company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
